These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34118488)

  • 1. Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase.
    Salloum S; Jeyarajan AJ; Kruger AJ; Holmes JA; Shao T; Sojoodi M; Kim MH; Zhuo Z; Shroff SG; Kassa A; Corey KE; Khan SK; Lin W; Alatrakchi N; Schaefer EAK; Chung RT
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1297-1310. PubMed ID: 34118488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease.
    Machado MV; Michelotti GA; Pereira TA; Xie G; Premont R; Cortez-Pinto H; Diehl AM
    J Hepatol; 2015 Oct; 63(4):962-70. PubMed ID: 26070409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.
    Zhang X; Li S; Zhou Y; Su W; Ruan X; Wang B; Zheng F; Warner M; Gustafsson JÅ; Guan Y
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3181-3185. PubMed ID: 28270609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.
    Mooring M; Fowl BH; Lum SZC; Liu Y; Yao K; Softic S; Kirchner R; Bernstein A; Singhi AD; Jay DG; Kahn CR; Camargo FD; Yimlamai D
    Hepatology; 2020 May; 71(5):1813-1830. PubMed ID: 31505040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
    Engin A
    Adv Exp Med Biol; 2024; 1460():539-574. PubMed ID: 39287864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD.
    Pantano L; Agyapong G; Shen Y; Zhuo Z; Fernandez-Albert F; Rust W; Knebel D; Hill J; Boustany-Kari CM; Doerner JF; Rippmann JF; Chung RT; Ho Sui SJ; Simon E; Corey KE
    Sci Rep; 2021 Sep; 11(1):18045. PubMed ID: 34508113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease.
    Shen X; Guo H; Xu J; Wang J
    J Cell Physiol; 2019 Aug; 234(10):18169-18179. PubMed ID: 30908654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36.
    Shen C; Chen JH; Oh HR; Park JH
    FEBS Lett; 2021 Oct; 595(19):2493-2503. PubMed ID: 34536973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of non-alcoholic fatty liver disease mediated by YAP.
    Chen P; Luo Q; Huang C; Gao Q; Li L; Chen J; Chen B; Liu W; Zeng W; Chen Z
    Hepatol Int; 2018 Jan; 12(1):26-36. PubMed ID: 29330836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
    Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
    J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice.
    Yang P; Wang Y; Tang W; Sun W; Ma Y; Lin S; Jing J; Jiang L; Shi H; Song Z; Yu L
    Sci Rep; 2020 Mar; 10(1):4701. PubMed ID: 32170127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis.
    Xie G; Jiang R; Wang X; Liu P; Zhao A; Wu Y; Huang F; Liu Z; Rajani C; Zheng X; Qiu J; Zhang X; Zhao S; Bian H; Gao X; Sun B; Jia W
    EBioMedicine; 2021 Apr; 66():103290. PubMed ID: 33752128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
    Liu X; Henkel AS; LeCuyer BE; Schipma MJ; Anderson KA; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G965-74. PubMed ID: 26472223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
    Li BH; He FP; Yang X; Chen YW; Fan JG
    Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease.
    Liang D; Chen H; Zhao L; Zhang W; Hu J; Liu Z; Zhong P; Wang W; Wang J; Liang G
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):133-142. PubMed ID: 29038049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells.
    Yan R; Cai H; Zhou X; Bao G; Bai Z; Ge RL
    Front Endocrinol (Lausanne); 2024; 15():1344971. PubMed ID: 38501098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis.
    Qing J; Ren Y; Zhang Y; Yan M; Zhang H; Wu D; Ma Y; Chen Y; Huang X; Wu Q; Mazhar M; Wang L; Liu J; Ding BS; Cao Z
    J Hepatol; 2022 Feb; 76(2):394-406. PubMed ID: 34648896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.